Gambogic Acid Efficiently Kills Stem-Like Colorectal Cancer Cells by Upregulating ZFP36 Expression

Background/Aims: Gambogic acid (GA), the main active compound of Gamboge hanburyi, has been reported to be a potential novel antitumor drug. Whether GA inhibits putative cancer stem cells (CSCs), which are considered to be the major cause of cancer treatment failure, remains largely unknown. This study investigated whether GA inhibits the CSCs of colorectal cancer (CRC) and its possible mechanisms. Methods: We performed CCK8 and tumor sphere formation assays, percentage analysis of both side population and CD133+CD44+ cells, and the detection of stem cells markers, in order to assess the role of GA in inhibiting the stem celllike features of CRC. An mRNA microarray was performed to identify the downstream gene affected by GA and rescue assays were performed to further clarify whether the downstream gene is involved in the GA induced decrease of the stem cell-like CRC population. CRC cells were engineered with a CSC detector vector encoding GFP and luciferase (Luc) under the control of the Nanog promoter, which were utilized to investigate the effect of GA on putative CSC in human tumor xenograft-bearing mice using in vivo bioluminescence imaging. Results: Our results showed that GA significantly reduced tumor sphere formation and the percentages of side population and CD133+CD44+ cells, while also decreasing the expression of stemness and EMT-associated markers in CRC cells in vitro. GA killed stem-like CRC cells by upregulating the expression of ZFP36, which is dependent on the inactivation of the EGFR/ ERK signaling pathway. GFP+ cells harboring the PNanog-GFP-T2A-Luc transgene exhibited CSC characteristics. The in vivo results showed that GA significantly inhibited tumor growth in nude mice, accompanied by a remarkable reduction in the putative CSC number, based on whole-body bioluminescence imaging. Conclusion: These findings suggest that GA significantly inhibits putative CSCs of CRC both in vitro and in vivo by inhibiting the activation of the EGFR/ ERK/ZFP36 signaling pathway and may be an effective drug candidate for anticancer therapies.

[1]  Xinyu Huang,et al.  Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2) , 2017, Journal of Experimental & Clinical Cancer Research.

[2]  V. Gopalan,et al.  The Identifications and Clinical Implications of Cancer Stem Cells in Colorectal Cancer. , 2017, Clinical colorectal cancer.

[3]  A. Berghold,et al.  Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients. , 2017, Anticancer research.

[4]  Baorui Liu,et al.  Gambogic acid-loaded biomimetic nanoparticles in colorectal cancer treatment , 2017, International journal of nanomedicine.

[5]  S. Bortoluzzi,et al.  Loss of zfp36 expression in colorectal cancer correlates to wnt/ β-catenin activity and enhances epithelial-to-mesenchymal transition through upregulation of zeb1, sox9 and macc1 , 2016, Oncotarget.

[6]  Hongwei Gong,et al.  Reversing drug resistance of soft tumor-repopulating cells by tumor cell-derived chemotherapeutic microparticles , 2016, Cell Research.

[7]  Limei Liu,et al.  IGF/STAT3/NANOG/Slug Signaling Axis Simultaneously Controls Epithelial‐Mesenchymal Transition and Stemness Maintenance in Colorectal Cancer , 2016, Stem cells.

[8]  Jun Du,et al.  CCL21 Facilitates Chemoresistance and Cancer Stem Cell-Like Properties of Colorectal Cancer Cells through AKT/GSK-3β/Snail Signals , 2015, Oxidative medicine and cellular longevity.

[9]  E. Nishida,et al.  HOXA5 Counteracts Stem Cell Traits by Inhibiting Wnt Signaling in Colorectal Cancer. , 2015, Cancer cell.

[10]  Yan Sun,et al.  Cytokine-induced killer cells efficiently kill stem-like cancer cells of nasopharyngeal carcinoma via the NKG2D-ligands recognition , 2015, Oncotarget.

[11]  A. Iwamoto,et al.  Gambogic acid inhibits growth, induces apoptosis, and overcomes drug resistance in human colorectal cancer cells , 2015, International journal of oncology.

[12]  Jeffrey S. Morris,et al.  The Consensus Molecular Subtypes of Colorectal Cancer , 2015, Nature Medicine.

[13]  Ai-min Li,et al.  Recognition and killing of cancer stem-like cell population in hepatocellular carcinoma cells by cytokine-induced killer cells via NKG2d-ligands recognition , 2015, Oncoimmunology.

[14]  Foteini Hassiotou,et al.  Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target. , 2015, Carcinogenesis.

[15]  D. Peng,et al.  Gambogic acid-loaded electrosprayed particles for site-specific treatment of hepatocellular carcinoma. , 2014, Molecular pharmaceutics.

[16]  T. Lappin,et al.  Concise Reviews: Cancer Stem Cells: From Concept to Cure , 2014, Stem cells.

[17]  C. Cordon-Cardo,et al.  Targeting cancer stem cells to suppress acquired chemotherapy resistance , 2014, Oncogene.

[18]  D. Xiao,et al.  MicroRNA-122 Triggers Mesenchymal-Epithelial Transition and Suppresses Hepatocellular Carcinoma Cell Motility and Invasion by Targeting RhoA , 2014, PloS one.

[19]  Tao Chen,et al.  Improving aqueous solubility and antitumor effects by nanosized gambogic acid-mPEG2000 micelles , 2013, International journal of nanomedicine.

[20]  Q. Dou,et al.  Gambogic Acid Induces Apoptosis in Imatinib-Resistant Chronic Myeloid Leukemia Cells via Inducing Proteasome Inhibition and Caspase-Dependent Bcr-Abl Downregulation , 2013, Clinical Cancer Research.

[21]  D. Xiao,et al.  The enforced expression of c-Myc in pig fibroblasts triggers mesenchymal-epithelial transition (MET) via F-actin reorganization and RhoA/Rock pathway inactivation , 2013, Cell cycle.

[22]  N. D’Silva,et al.  Inactivation or Loss of TTP Promotes Invasion in Head and Neck Cancer via Transcript Stabilization and Secretion of MMP9, MMP2, and IL-6 , 2013, Clinical Cancer Research.

[23]  Hong Wang,et al.  EGF signalling pathway regulates colon cancer stem cell proliferation and apoptosis , 2012, Cell proliferation.

[24]  P. Blackshear,et al.  Tristetraprolin Impairs Myc-Induced Lymphoma and Abolishes the Malignant State , 2012, Cell.

[25]  Yolanda Fernández,et al.  β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer , 2012, Nature Medicine.

[26]  C. Gemelli,et al.  ZFP36 expression impairs glioblastoma cell lines viability and invasiveness by targeting multiple signal transduction pathways , 2012, Cell cycle.

[27]  S. Eccles.  The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology. , 2011, The International journal of developmental biology.

[28]  N. Mazure,et al.  Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells. , 2011, American journal of physiology. Cell physiology.

[29]  B. Lee,et al.  Tristetraprolin downregulates the expression of both VEGF and COX-2 in human colon cancer. , 2011, Hepato-gastroenterology.

[30]  J. Shao,et al.  Epstein-Barr Virus-Encoded LMP2A Induces an Epithelial–Mesenchymal Transition and Increases the Number of Side Population Stem-like Cancer Cells in Nasopharyngeal Carcinoma , 2010, PLoS pathogens.

[31]  Joseph C. Wu,et al.  Long term non-invasive imaging of embryonic stem cells using reporter genes , 2009, Nature Protocols.

[32]  Sarah E. Brennan,et al.  The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis. , 2009, Cancer research.

[33]  R. Wickremasinghe,et al.  Involvement of Tis11b, an AU-rich binding protein, in induction of apoptosis by rituximab in B cell chronic lymphocytic leukemia cells , 2009, Leukemia.

[34]  M. Ratajczak,et al.  Mouse fibroblasts lacking RB1 function form spheres and undergo reprogramming to a cancer stem cell phenotype. , 2009, Cell stem cell.

[35]  Yong Yang,et al.  Anti-invasive effect of gambogic acid in MDA-MB-231 human breast carcinoma cells. , 2008, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[36]  W. El-Deiry,et al.  Invincible, but not invisible: imaging approaches toward in vivo detection of cancer stem cells. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[38]  Mingyao Liu,et al.  Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling. , 2008, Cancer research.

[39]  B. Aggarwal,et al.  Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappaB signaling pathway. , 2007, Blood.

[40]  L. Ricci-Vitiani,et al.  Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.

[41]  R. Vartanian,et al.  Tristetraprolin regulates Cyclin D1 and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling , 2006, Oncogene.

[42]  Hai-wei Zhang,et al.  Gambogic acid-induced G2/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcinoma BGC-823 cells. , 2006, Carcinogenesis.

[43]  J. Wang-Rodriguez,et al.  EGFR Regulates the Side Population in Head and Neck Squamous Cell Carcinoma , 2006, The Laryngoscope.

[44]  Q. Qi,et al.  Inhibition of human telomerase reverse transcriptase gene expression by gambogic acid in human hepatoma SMMC-7721 cells. , 2006, Life sciences.

[45]  N. Normanno,et al.  Epidermal growth factor receptor (EGFR) signaling in cancer. , 2006, Gene.

[46]  Q. You,et al.  Gambogic acid inhibits proliferation of human lung carcinoma SPC-A1 cells in vivo and in vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cells. , 2004, Biological & pharmaceutical bulletin.

[47]  Q. You,et al.  Gambogic acid induces apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric carcinoma MGC-803 cells. , 2004, Biological & pharmaceutical bulletin.

[48]  J. Barker,et al.  Prospective Cell Sorting of Embryonic Rat Neural Stem Cells and Neuronal and Glial Progenitors Reveals Selective Effects of Basic Fibroblast Growth Factor and Epidermal Growth Factor on Self-Renewal and Differentiation , 2003, The Journal of Neuroscience.

[49]  Y. Tsushima,et al.  In vivo molecular imaging of cancer stem cells. , 2015, American journal of nuclear medicine and molecular imaging.

[50]  D. Xiao,et al.  Generation of Rm21LG transgenic mice: a powerful tool to generate conditional overexpression of miR-21 that is involved in oncogenesis , 2013, Biotechnology Letters.

[51]  F. Aberger,et al.  Cooperative Hedgehog-EGFR signaling. , 2012, Frontiers in bioscience.

[52]  C. Gemelli,et al.  ZFP 36 expression impairs glioblastoma cell lines viability and invasiveness by targeting multiple signal transduction pathways , 2012 .

[53]  Qing Zhao,et al.  Posttranscriptional regulation of the telomerase hTERT by gambogic acid in human gastric carcinoma 823 cells. , 2008, Cancer letters.